Delivery Order SPE2DB20D3303-SPE2DB24FZ0F6

Award Date 2/23/24
Potential Completion Date 2/26/24
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the AmerisourceBergen Corporation. The $3,562.80 contract is for the provision of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This delivery order is placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,958.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract has a potential value of $1,911.67 and a completion date of March 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,447.33 for the supply of Lantus Solostar insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lantus Solostar 100 unit/ml 3ml insulin pens. The contract has a completion date of January 29, 2024 and a potential value of $2,338.88. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,781.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Lantus SoloStar insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,943.76 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lantus Solostar 100 unit/mL 3mL insulin pens. The $1,187.60 award has an ultimate completion date of April 4, 2024. This delivery order falls under Amerisourcebergen Drug Corp's $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to supply a...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Lantus Solostar 100 unit/ml 3ml insulin pens. The $1,850.53 contract has a performance period through March 12, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation, a leading global pharmaceutical distribution company, to provide Lantus Solostar 100 unit/ml 3ml insulin pens. The $1,187.60 firm fixed price delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that runs through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FZ0F6
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,129.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens, with a completion date of February 26, 2024. This delivery order is issued under a larger, single award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.

Generated 5/24/24, 10:05 AM